Loading...
•
Mar 31, 2021
CME Group Q1 2021 Earnings Report
Reported financial results for the first quarter of 2021.
Key Takeaways
CME Group reported a strong first quarter in 2021 with increased demand for products due to potential post-pandemic economic recovery. The company's revenue was $1.3 billion, and operating income was $725 million. Net income was $574 million, with diluted earnings per share at $1.60.
Experienced strong demand for products as clients looked to manage risks associated with the potential for a post-pandemic economic recovery.
Trading volumes in Q1 have returned to pre-pandemic levels.
ADV in the first quarter representing our third-highest quarterly ADV ever, and open interest climbing above 100 million contracts.
Continue to deliver against our growth objectives, introducing several innovative, new products, completing migration of BrokerTec to CME Globex and agreeing to form a joint venture for post-trade services in OTC markets.
CME Group
CME Group
CME Group Revenue by Segment
Revenue by Segment
Clearing & transaction fees Revenue
CapyFin.comMarket data services Revenue
CapyFin.comOther services Revenue
CapyFin.com Forward Guidance
The press release contains forward-looking statements with risks, uncertainties, and assumptions that are difficult to predict, and actual outcomes and results may differ materially from what is expressed or implied in any forward-looking statements.
Challenges Ahead
- Increasing competition by foreign and domestic entities.
- Ability to keep pace with rapid technological developments.
- Ability to continue introducing competitive new products and services on a timely, cost-effective basis.
- Ability to adjust fixed costs and expenses if revenues decline.
- Ability to maintain existing customers at substantially similar trading levels, develop strategic relationships and attract new customers.
Revenue & Expenses
Visualization of income flow from segment revenue to net income